Chevy Chase Trust
MEDP icon

Chevy Chase Trust’s Medpace MEDP Stock Holding History

Chevy Chase Trust’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.81M Sell
14,745
-110
-0.7% -$50.8K 0.02% 454
2026
Q1 		$7.13M Buy
14,855
+7,864
+112% +$4.03M 0.02% 469
2025
Q4 		$3.93M Sell
6,991
-211
-3% -$120K 0.01% 535
2025
Q3 		$3.7M Sell
7,202
-7,929
-52% -$3.46M 0.01% 535
2025
Q2 		$4.75M Buy
15,131
+219
+1% +$65.7K 0.01% 514
2025
Q1 		$4.54M Sell
14,912
-51
-0.3% -$17.2K 0.01% 517
2024
Q4 		$4.97M Sell
14,963
-213
-1% -$72.2K 0.02% 509
2024
Q3 		$5.07M Buy
15,176
+6,230
+70% +$2.37M 0.02% 515
2024
Q2 		$3.68M Sell
8,946
-3,238
-27% -$1.28M 0.01% 529
2024
Q1 		$4.92M Sell
12,184
-35
-0.3% -$12.3K 0.02% 509
2023
Q4 		$3.75M Sell
12,219
-299
-2% -$80.7K 0.01% 530
2023
Q3 		$3.03M Sell
12,518
-121
-1% -$30.9K 0.01% 523
2023
Q2 		$3.04M Sell
12,639
-236
-2% -$49K 0.01% 527
2023
Q1 		$2.42M Sell
12,875
-279
-2% -$57.7K 0.01% 536
2022
Q4 		$2.79M Sell
13,154
-8,207
-38% -$1.64M 0.01% 542
2022
Q3 		$3.36M Buy
21,361
+358
+2% +$57.1K 0.01% 524
2022
Q2 		$3.14M Buy
21,003
+4,047
+24% +$586K 0.01% 525
2022
Q1 		$2.77M Buy
16,956
+443
+3% +$73K 0.01% 534
2021
Q4 		$3.59M Sell
16,513
-289
-2% -$60.5K 0.01% 533
2021
Q3 		$3.18M Buy
16,802
+21
+0.1% +$3.83K 0.01% 535
2021
Q2 		$2.96M Sell
16,781
-337
-2% -$58.2K 0.01% 539
2021
Q1 		$2.81M Sell
17,118
-3,430
-17% -$525K 0.01% 539
2020
Q4 		$2.81M Sell
20,548
-5,241
-20% -$661K 0.01% 533
2020
Q3 		$2.88M Buy
+25,789
New +$2.98M 0.01% 519

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Chevy Chase Trust's MEDP Position: Q2 2026 in Review

Chevy Chase Trust reduced its Medpace (MEDP) stake by 0.74% in Q2 2026, selling an estimated $50.8K and leaving 14,745 shares worth $7.81M. The position accounts for 0.02% of the portfolio, ranked #454.

Chevy Chase Trust first reported a position in MEDP in Q3 2020 and has held it in 24 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Chevy Chase Trust held 14,745 shares of Medpace worth $7.81M as of Q2 2026.
  • Chevy Chase Trust sold 110 Medpace shares in Q2 2026, an estimated $50.8K.
  • Medpace made up 0.02% of Chevy Chase Trust's portfolio in Q2 2026, its #454 holding.
  • Chevy Chase Trust first reported a position in Medpace in Q3 2020 and has held it in 24 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.